Clinical Trial Update: Donafenib Monotherapy for Previously Treated Metastatic Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of Phase 1 and Phase 2 trials of donafenib as monotherapy for previously treated metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Donafenib (donafenib)

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Metastatic Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED